GWAY Insider Trading Activity and SEC Form 4 Filings
GWAY insider trading summary
No open-market insider purchases or sales of Greenway Medical Technologies Inc (GWAY) have been reported on SEC Form 4 in the past 12 months.
Latest GWAY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 13, 2013 | Walter Turek | Director | Buy | $57K (4,400 @ $12.98) |
| May 9, 2013 | Walter Turek | Director | Buy | $71K (5,600 @ $12.64) |
| Mar 5, 2013 | W T Green Jr | Chairman | Sell | $62K (3,800 @ $16.27) |
| Feb 21, 2013 | James A Cochran | Chief Financial Officer | Sell | $153K (10,000 @ $15.30) |
| Feb 15, 2013 | Robert Z Hensley | Director | Buy | $30K (2,000 @ $14.93) |
| Dec 7, 2012 | W T Green Jr | Chairman | Sell | $27K (1,500 @ $18.05) |
| Dec 6, 2012 | W T Green Jr | Chairman | Sell | $119K (6,600 @ $18.00) |
| Nov 29, 2012 | James A Cochran | Chief Financial Officer | Sell | $194K (10,000 @ $19.39) |
| Nov 9, 2012 | Robert Z Hensley | Director | Buy | $49K (3,000 @ $16.18) |
| Nov 6, 2012 | James A Cochran | Chief Financial Officer | Sell | $248K (15,000 @ $16.52) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.